Abeta-mediated toxicity in Alzheimer's disease: delineating mechanisms of internalisation, cell-cell transmission and synaptic dysfunction
Abeta-mediated toxicity in Alzheimer's disease: delineating mechanisms of internalisation, cell-cell transmission and synaptic dysfunction
批准号:
MR/K022105/1
负责人:
Louise Serpell
金额:
$51.97万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2013
资助国家:
英国
项目状态:
已结题
起止时间:
2013 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Alzheimer's disease (AD) is a devastating illness that affects 1% of the population. Although some familial forms of AD exist, most Alzheimer's patients suffer from sporadic, late-onset AD, associated with ageing. The causes of Alzheimer's disease remain unclear, although it is now well-established that in brain cells (neurons), abnormal folding of small proteins (called Abeta and tau) represents a pivotal step in disease pathology. Our work aims to understand how these proteins can lead to the deterioration of neuronal function underlying the degenerative symptoms seen in Alzheimer's sufferers. To examine this we will use both artificially-grown and native networks of living neurons and recapitulate the changes occurring at the onset of AD as the target proteins change and become toxic. We will utilise state-of-the-art imaging methods to directly visualise the effects on basic neuronal function. Our research will also examine how the spread of toxic proteins between neurons might underlie the progression of the disease. A specific consequence of AD is the gradual dysfunction of synapses - the sites for neuron-to-neuron signalling - that are essential for the brain's ability to process information. We will use specialised fluorescence markers to examine synaptic signalling events and characterise the specific mechanisms which become disrupted. Finally, we will combine our fluorescence measurements with novel state-of-the-art microscopy experiments, allowing us to examine the detailed structural changes in neurons caused by misfolding proteins at high-resolution. Using this approach, we anticipate major new insights into understanding the critical cellular and molecular changes associated with Alzheimer's disease. With this knowledge, the rational design of therapeutic agents that can target these processes and alleviate or prevent disease symptoms becomes a realistic prospect.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1093/cercor/bhac134
发表时间:
2023-02-07
期刊:
Cerebral cortex (New York, N.Y. : 1991)
影响因子:
--
作者:
[]
通讯作者:
The suprastructure-function relationship between amyloid assemblies and their toxic and infectious potentials
-
批准号:BB/S003657/1
-
项目类别:Research Grant
-
资助金额:$35.64万
-
财政年份:2019
-
负责人:Louise Serpell
-
依托单位:
High resolution studies to examine the amyloid core and oligomeric intermediates
-
批准号:BB/E009042/1
-
项目类别:Research Grant
-
资助金额:$45.68万
-
财政年份:2007
-
负责人:Louise Serpell
-
依托单位:
国内基金
海外基金
登录
查看更多内容
PfAP2-R介导的PfCRT转录调控在恶性疟原虫对喹啉类药物抗性中的作用及机制研究
-
批准号:82372275
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:刘耀宝
-
依托单位:
基于NLRP3/IL-1β信号探讨α7nAChR介导巨噬细胞—心肌细胞互作在Aβ诱导房颤心房重构中的作用及机制研究
-
批准号:82300356
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:赵继凯
-
依托单位:
Tom1L1在胞内体蛋白分选机制中功能的研究
-
批准号:31171289
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2011
-
负责人:刘宁生
-
依托单位:
溶酶体依赖性TRAF2降解的机制
-
批准号:30971501
-
项目类别:面上项目
-
资助金额:31.0万元
-
批准年份:2009
-
负责人:李联运
-
依托单位: